News

Ted Harris, Chairman, President and CEO said, “We delivered solid second quarter financials with record earnings from operations and adjusted EBITDA. I am particularly pleased with the excellent performance in our Human Nutrition and Health and Specialty Products segments, both delivering strong sales and earnings growth.”

Join Ted Harris, Chairman of the Board, President, and CEO and Martin Bengtsson, CFO on Friday, October 25, 2024, at 11:00 AM Eastern Time (ET) to review 3rd Quarter 2024 financial results.

Ted Harris, Chairman, President and CEO said, “We delivered solid second quarter financials with record earnings from operations and adjusted EBITDA. I am particularly pleased with the excellent performance in our Human Nutrition and Health and Specialty Products segments, both delivering strong sales and earnings growth.”

Join Ted Harris, Chairman of the Board, President, and CEO and Martin Bengtsson, CFO on Friday, July 26, 2024, at 11:00 AM Eastern Time (ET) to review 2nd Quarter 2024 financial results.

Ted Harris, Chairman, President and CEO of Balchem said, “The first quarter was a very good start to the year for Balchem. We delivered record net sales, adjusted EBITDA, and net earnings, as well as solid first quarter cash flows, despite the continued challenging environment in parts of our portfolio.”

Balchem Corporation today released its 2023 Sustainability Report, which captures the Company’s commitment to managing our Environmental, Social and Governance (ESG) performance.

Join Ted Harris, Chairman of the Board, President, and CEO and Martin Bengtsson, CFO on Friday, May 3, 2024, at 11:00 AM Eastern Time (ET) to review 1st Quarter 2024 financial results.

Ted Harris, Chairman, CEO, and President of Balchem said, “Our full year 2023 results highlight the resilience of our business model in a challenging and volatile market environment.”

Join Ted Harris, Chairman of the Board, President, and CEO and Martin Bengtsson, CFO on Friday, February 16, 2024, at 11:00 AM Eastern Time (ET) to review 4th Quarter 2023 financial results.

Balchem named one of America’s Most Responsible Companies by Newsweek magazine for the fourth consecutive year.

Ted Harris, Balchem’s Chairman, President, and CEO, said, “Balchem has a long-standing commitment to an annual dividend and we are pleased to announce the continuation of that commitment.”

Ted Harris, Chairman, President, and CEO of Balchem said, “I am very pleased with our third quarter performance. We delivered record Adjusted EBITDA as a result of improved mix, manufacturing efficiencies, and easing inflationary pressures.”

Join Ted Harris, Chairman of the Board, President and CEO and Martin Bengtsson, CFO on Friday, October 27, 2023, at 11:00 AM Eastern Time (ET) to review third quarter financial results.

Ted Harris, Chairman, President, and CEO of Balchem said, “We delivered solid second quarter financials, and I am particularly pleased with our strong profitability and margin performance as we move forward from the highly inflationary period we experienced over the last two years.”

Join Ted Harris, Chairman of the Board, President and CEO and Martin Bengtsson, CFO on Friday, July 28, 2023, at 11:00 AM Eastern Time (ET) to review second quarter financial results.

Ted Harris, Chairman, President, and CEO of Balchem said, “We delivered solid first quarter financial performance with sales and adjusted EBITDA growth both compared to prior year’s very strong results, and sequentially compared to the fourth quarter of 2022.

Balchem Corporation today released its 2022 Sustainability Report, which captures the Company’s commitment to managing our Environmental, Social and Governance (ESG) performance.

Join Ted Harris, Chairman of the Board, President and CEO and Martin Bengtsson, CFO on Friday, April 28, 2023, at 11:00 AM Eastern Time (ET) to review first quarter financial results.

Ted Harris, Chairman, CEO, and President of Balchem said, “The fourth quarter capped off another strong year for Balchem.  For the full year, we achieved record sales of $942 million dollars, growing almost 18 percent year over year, with record sales in all three of our business segments.”

Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, February 24th at 11:00 AM Eastern Time (ET) to review 4th Quarter 2022 results.

Balchem named one of America’s Most Responsible Companies by Newsweek magazine for the third consecutive year.

Ted Harris, Balchem’s Chairman, President, and CEO, said, “Balchem has a long-standing commitment to an annual dividend and we are pleased to announce the continuation of that commitment.”

Ted Harris, Chairman, President and CEO of Balchem said, “The third quarter of 2022 was another solid growth quarter for Balchem as we delivered both sales and earnings growth year over year in an increasingly challenging macro-economic environment.”

Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, November 4th at 11:00 AM Eastern Time (ET) to review 3rd Quarter 2022 results.

Balchem Corporation is excited to announce the acquisition of Cardinal Associates Inc., operating as “Bergstrom Nutrition,” a leading science-based manufacturer of methylsulfonylmethane (MSM), based in Vancouver, Washington.

Ted Harris, Chairman, CEO, and President of Balchem said, “The second quarter of 2022 was another excellent quarter for Balchem. We delivered very strong financial results with record sales and adjusted EBITDA in what remains a very difficult macro-economic and geo-political environment.”

Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, July 29th at 11:00 AM Eastern Time (ET) to review 2nd Quarter 2022 results.

We are excited to announce that we completed our acquisition of Kappa Bioscience AS, a leading science-based manufacturer of specialty vitamin K2 for the human nutrition industry, headquartered in Oslo, Norway.

Balchem has signed a definitive agreement to acquire Kappa Bioscience AS, a leading science-based manufacturer of specialty vitamin K2 for the human nutrition industry, headquartered in Oslo, Norway.

A paper just published in The American Journal of Clinical Nutrition (AJCN) highlights the unique role choline plays in enhancing docosahexaenoic acid (DHA) status during pregnancy.

Ted Harris, Chairman, CEO, and President of Balchem said, “We are very pleased to have continued the strong momentum from 2021 into 2022. In the first quarter of 2022 we delivered all-time record sales, adjusted net earnings, and adjusted EBITDA in a very difficult macro-economic and geo-political environment.”

Balchem Corporation today released its 2021 Sustainability Report, which captures the Company’s commitment to managing our Environmental, Social and Governance (ESG) performance.

Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, April 29th at 11:00 AM Eastern Time (ET) to review 1st Quarter 2022 results.

Ted Harris, Chairman, CEO, and President of Balchem said, “The Balchem team delivered an excellent fourth quarter performance, setting new records for sales and adjusted EBITDA, while delivering solid sales growth in all three reporting segments and consolidated organic volume growth of almost 8%. We also delivered strong cash flows, showing consistency in translating our profits into cash.”

Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, February 18th at 11:00 AM Eastern Time (ET) to review 4th Quarter 2021 results.

Balchem named one of America’s Most Responsible Companies by Newsweek magazine for the second consecutive year.

Join Ted Harris, CEO and Martin Bengtsson, CFO to learn more about Balchem at the CJS Securities 22nd Annual New Ideas for the New Year Conference on January 12, 2022.

Join Ted Harris, CEO and Martin Bengtsson, CFO to learn more about Balchem at the H.C. Wainwright BIOCONNECT Virtual Conference on January 10, 2022.

Ted Harris, Balchem’s CEO and President, said, “Balchem has a long-standing commitment to an annual dividend and we are pleased to announce the continuation of that commitment.”

Join Ted Harris, CEO and Martin Bengtsson, CFO to learn more about Balchem at the Baird 2021 Global Industrial Conference on November 10, 2021.

Ted Harris, Chairman, CEO, and President said, “Our performance this quarter reflects the strength of our global market positions as well as the resilience of our business model. We delivered record third quarter sales in all three of our reporting segments as well as record earnings while facing an extraordinarily difficult macro economic environment with global supply chain disruptions and input cost inflation.”

Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, October 29th at 11:00 AM Eastern Time (ET) to review 3rd Quarter 2021 results.

Ted Harris, Chairman, CEO, and President of Balchem said, “The second quarter of 2021 was another strong quarter for Balchem. We delivered exceptional performance in a dynamic market environment and we continued to see strong demand for our products and services.”

Join Ted Harris, CEO, and Martin Bengtsson, CFO to learn more about Balchem at the Jefferies Virtual Industrials Conference on 8/4/21.

Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, July 30th at 11:00 AM Eastern Time (ET) to review 2nd Quarter 2021 results.

Join Ted Harris, CEO, and Martin Bengtsson, CFO to learn more about Balchem at the Stephens Food & Ag Disrupted: Public-Private Conference on 5/25/21.

Ted Harris, Chairman, CEO, and President of Balchem said, “We have continued the strong momentum from 2020 into the first quarter of 2021, delivering all-time record quarterly sales, net earnings, earnings per share, and adjusted EBITDA.”

Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, April 30 at 11:00 AM Eastern Time (ET) to review 1st Quarter 2021 results.

Join Ted Harris, CEO, and Martin Bengtsson, CFO to learn more about Balchem at the J.P. Morgan Industrials Conference on March 15, 2021.

Learn more about chelation and Balchem’s Metalosate products.

Ted Harris, Chairman, CEO, and President of Balchem said, “With these strong fourth quarter results, the Balchem team delivered another excellent quarterly performance. Our fourth quarter results reflected sales growth in all three segments and continued strong earnings and cash flow conversion.”

Join Ted Harris, CEO, and Martin Bengtsson, CFO, to learn more about Balchem at the H.C. Wainwright Fireside Chat on February 24, 2021.

Learn more about how Balchem Human Nutrition and Health products can help with Creatine Supplementation.

Join Ted Harris, CEO, and Martin Bengtsson, CFO, on February 19th at 11:00 AM Eastern Time (ET) to review 2020 fourth quarter results.

Join Ted Harris, CEO, and Martin Bengtsson, CFO, to learn more about Balchem at the Sidoti & Company LLC Virtual Investor Conference on January 13, 2021.

Balchem declares a dividend on its shares of common stock equal to $0.58 per share which represents the eleventh consecutive increase.

Join Ted Harris, CEO, and Martin Bengtsson, CFO, to learn more about Balchem at the Stephens Annual Investment Conference 2020 on November 17, 2020

Join Ted Harris, CEO, and Martin Bengtsson, CFO, to learn more about Balchem at Baird’s 2020 Global Industrial Conference on November 12, 2020

Balchem Acquires Zumbro River Brand, Inc.

Balchem Corporation (NASDAQ: BCPC) today announced that it has signed a definitive agreement to acquire Chemogas NV, a privately held specialty gases company, headquartered in Grimbergen, Belgium.

Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, May 3, 2019 at 11:00 AM Eastern Time (ET) to review first quarter results.

Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Thursday, February 28, 2019.